CLRB
Price
$0.30
Change
-$0.00 (-0.00%)
Updated
Apr 24, 02:21 PM (EDT)
Capitalization
13.95M
13 days until earnings call
ENTA
Price
$5.46
Change
-$0.14 (-2.50%)
Updated
Apr 24, 02:24 PM (EDT)
Capitalization
117.33M
18 days until earnings call
Ad is loading...

CLRB vs ENTA

Header iconCLRB vs ENTA Comparison
Open Charts CLRB vs ENTABanner chart's image
Cellectar Biosciences
Price$0.30
Change-$0.00 (-0.00%)
Volume$500
Capitalization13.95M
Enanta Pharmaceuticals
Price$5.46
Change-$0.14 (-2.50%)
Volume$100
Capitalization117.33M
CLRB vs ENTA Comparison Chart
Loading...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRB vs. ENTA commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a StrongBuy and ENTA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CLRB: $0.31 vs. ENTA: $5.60)
Brand notoriety: CLRB and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 39% vs. ENTA: 45%
Market capitalization -- CLRB: $13.95M vs. ENTA: $117.33M
CLRB [@Biotechnology] is valued at $13.95M. ENTA’s [@Biotechnology] market capitalization is $117.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green whileENTA’s FA Score has 1 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTA is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 6 TA indicator(s) are bullish while ENTA’s TA Score has 5 bullish TA indicator(s).

  • CLRB’s TA Score: 6 bullish, 3 bearish.
  • ENTA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CLRB is a better buy in the short-term than ENTA.

Price Growth

CLRB (@Biotechnology) experienced а +9.57% price change this week, while ENTA (@Biotechnology) price change was +13.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

CLRB is expected to report earnings on Aug 18, 2025.

ENTA is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($117M) has a higher market cap than CLRB($14M). CLRB YTD gains are higher at: 3.779 vs. ENTA (-2.609). CLRB has higher annual earnings (EBITDA): -51.29M vs. ENTA (-94.42M). ENTA has more cash in the bank: 217M vs. CLRB (34.3M). CLRB has less debt than ENTA: CLRB (513K) vs ENTA (57.5M). ENTA has higher revenues than CLRB: ENTA (66.6M) vs CLRB (0).
CLRBENTACLRB / ENTA
Capitalization14M117M12%
EBITDA-51.29M-94.42M54%
Gain YTD3.779-2.609-145%
P/E RatioN/AN/A-
Revenue066.6M-
Total Cash34.3M217M16%
Total Debt513K57.5M1%
FUNDAMENTALS RATINGS
CLRB vs ENTA: Fundamental Ratings
CLRB
ENTA
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
661
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLRB's Valuation (60) in the Biotechnology industry is somewhat better than the same rating for ENTA (96). This means that CLRB’s stock grew somewhat faster than ENTA’s over the last 12 months.

CLRB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ENTA (100). This means that CLRB’s stock grew similarly to ENTA’s over the last 12 months.

ENTA's SMR Rating (95) in the Biotechnology industry is in the same range as CLRB (99). This means that ENTA’s stock grew similarly to CLRB’s over the last 12 months.

ENTA's Price Growth Rating (65) in the Biotechnology industry is in the same range as CLRB (65). This means that ENTA’s stock grew similarly to CLRB’s over the last 12 months.

ENTA's P/E Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for CLRB (66). This means that ENTA’s stock grew somewhat faster than CLRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLRBENTA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 17 days ago
83%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GVA77.991.36
+1.77%
Granite Construction
AVO10.620.14
+1.38%
Mission Produce
MKL1796.6811.48
+0.64%
Markel Group
NXGL2.70-0.06
-2.17%
NexGel
SEVN11.25-0.31
-2.68%
Seven Hills Realty Trust

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been closely correlated with QTTB. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
+2.48%
QTTB - CLRB
77%
Closely correlated
-1.05%
ADCT - CLRB
47%
Loosely correlated
+4.88%
ANAB - CLRB
45%
Loosely correlated
-5.47%
IBRX - CLRB
39%
Loosely correlated
-0.37%
CELC - CLRB
37%
Loosely correlated
-0.63%
More

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ALEC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+1.82%
ALEC - ENTA
36%
Loosely correlated
+6.31%
BEAM - ENTA
36%
Loosely correlated
+3.87%
PRME - ENTA
36%
Loosely correlated
+4.14%
ABOS - ENTA
35%
Loosely correlated
+3.86%
CLRB - ENTA
35%
Loosely correlated
+2.48%
More